87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
FDA grants fast track designation to drug combo for colorectal cancer

FDA grants fast track designation to drug combo for colorectal cancer

by April Wilkerson,University of OklahomaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal c

FDA grants fast track designation to drug combo for colorectal cancer

by April Wilkerson,University of OklahomaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal c
WISDOM trial weighs risk-based cancer screening

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based
Doctors say lung cancer is still the deadliest cancer, but hope is growing

Doctors say lung cancer is still the deadliest cancer, but hope is growing

by I. EdwardsLung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patie

Doctors say lung cancer is still the deadliest cancer, but hope is growing

by I. EdwardsLung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patie
uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li
HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
How to reduce risk of lymphedema after head and neck cancer

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe
Link between tumor metabolism and drug efficacy in cancer cells may help advance precision chemotherapy

Link between tumor metabolism and drug efficacy in cancer cells may help advance precision chemotherapy

byStonyBrookUniversityIntracellular regulation of PRMT5 activity and development of chemical probes CBH-001 and CBH-002. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-65558-6

Link between tumor metabolism and drug efficacy in cancer cells may help advance precision chemotherapy

byStonyBrookUniversityIntracellular regulation of PRMT5 activity and development of chemical probes CBH-001 and CBH-002. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-65558-6
Comprehensive study settles debate over diet safety for patients with cancer

Comprehensive study settles debate over diet safety for patients with cancer

by Jill Pease,University of FloridaCredit: Pixabay/CC0 Public DomainFor decades, patients undergoing blood cancer treatment have been told to avoid certain foods to reduce infection risk, guidance tha

Comprehensive study settles debate over diet safety for patients with cancer

by Jill Pease,University of FloridaCredit: Pixabay/CC0 Public DomainFor decades, patients undergoing blood cancer treatment have been told to avoid certain foods to reduce infection risk, guidance tha
FDA warns biotech firm over cancer drug claims

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a
MetaRing quickly identifies breast cancer drug sensitivity

MetaRing quickly identifies breast cancer drug sensitivity

by Hefei Institutes of Physical Science, Chinese Academy of SciencesSchematic illustration of the MetaRing platform for detecting paclitaxel treatment sensitivity in breast cancer. Credit: HUANG Guang

MetaRing quickly identifies breast cancer drug sensitivity

by Hefei Institutes of Physical Science, Chinese Academy of SciencesSchematic illustration of the MetaRing platform for detecting paclitaxel treatment sensitivity in breast cancer. Credit: HUANG Guang
Genomic test helps flag early aggressive prostate cancer in African American patients

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w